Companies

Search any private company and open it for the full read — what they raised, how they compare to peers, and who's behind it.

SectorThe company’s primary industry.
StageBased on the size of their most recent round.
CountryWhere the company is registered.
By default only operating companies show. Enable to include investment vehicles like funds and SPVs.
Reset
Sort by
CompanySectorLatest stageRaisedModeled value est.RoundsInvestors
Antigenics LLC/DE · LEXINGTONBiotechnologySeries C$100.0M$4.1B ($309.3M–$10.8B)10
Genesis Biopharma, Inc · WOODLAND HILLSBiotechnologySeries C$131.5M$4.1B ($309.3M–$10.8B)80
Stem Biotech LLC · KENNESAWBiotechnologySeries C$100.0M$4.1B ($309.3M–$10.8B)10
Alder Biopharmaceuticals Inc · BOTHELLBiotechnologySeries C$100.0M$4.1B ($309.3M–$10.8B)10
Argo AI Holdings, LLC · PITTSBURGHAI / MLSeries C$97.3M$4.0B ($368.7M–$10.5B)10
Kinnate Biopharma Inc. · SAN DIEGOBiotechnologySeries C$172.5M$3.9B ($303.1M–$10.3B)20
Arcutis Biotherapeutics, Inc. · WESTLAKE VILLAGEBiotechnologySeries C$94.5M$3.9B ($292.3M–$10.2B)10
Ideaya Biosciences, Inc. · South San FranciscoBiotechnologySeries C$111.4M$3.9B ($290.8M–$10.1B)20
Eastern Blockchain Technology Ltd. · KOWLOONCrypto / Web3Series C$100.0M$3.8B ($317.1M–$10.0B)10
Gear Blockchain, Inc · CHRIST CHURCHCrypto / Web3Series C$100.0M$3.8B ($317.1M–$10.0B)10
Stoke Therapeutics, Inc. · BedfordBiotechnologySeries C$90.8M$3.7B ($278.4M–$9.7B)20
4D Molecular Therapeutics Inc · EMERYVILLEBiotechnologySeries C$108.6M$3.7B ($278.4M–$9.7B)30
Perforce Holdings, Inc. · ALAMEDAComputersSeries C$97.4M$3.7B ($376.7M–$9.7B)10
DNA Research INST LLC · WEST PALM BEACHBiotechnologySeries C$94.5M$3.7B ($292.3M–$9.5B)10
M3 Biotechnology, Inc. · SEATTLEBiotechnologySeries C$107.3M$3.6B ($275.3M–$9.6B)40
Life Code Global Blockchain Technology Cloud Service & Datacenters Providers LLC · HOUSTONCrypto / Web3Series C$100.0M$3.6B ($317.1M–$9.3B)10
Ansun Biopharma, Inc. · SAN DIEGOPharmaSeries C$195.1M$3.5B ($324.8M–$9.2B)70
Verastem, Inc. · NEEDHAMPharmaceuticalsSeries C$163.2M$3.5B ($324.8M–$9.2B)60
Sutro Biopharma Inc · SOUTH SAN FRANCISCOBiotechnologySeries C$85.4M$3.5B ($264.1M–$9.2B)10
Checkmate Pharmaceuticals, Inc. · CAMBRIDGEBiotechnologySeries C$185.1M$3.5B ($263.2M–$9.2B)60
Black Diamond Therapeutics, Inc. · CAMBRIDGEBiotechnologySeries C$146.3M$3.5B ($262.9M–$9.2B)40
Rocket Software Inc · NEWTONComputersSeries C$91.9M$3.5B ($355.4M–$9.1B)10
Finch Therapeutics Group, Inc. · SOMERVILLEBiotechnologySeries C$179.9M$3.5B ($278.4M–$8.9B)30
Insmed Inc · RICHMONDBiotechnologySeries C$83.7M$3.4B ($259.0M–$9.0B)10
Shattuck Labs, Inc. · AUSTINBiotechnologySeries C$165.4M$3.4B ($256.7M–$9.0B)50
Armor Defense Inc. · RICHARDSONComputersSeries C$139.7M$3.3B ($343.7M–$8.8B)70
Evelo Biosciences, Inc. · CAMBRIDGEBiotechnologySeries C$131.5M$3.3B ($252.1M–$8.8B)20
TScan Therapeutics, Inc. · WalthamBiotechnologySeries C$123.3M$3.3B ($309.3M–$8.2B)20
Edgewise Therapeutics, Inc. · BoulderBiotechnologySeries C$120.1M$3.3B ($293.9M–$8.2B)20
Bellicum Pharmaceuticals, Inc · HOUSTONPharmaceuticalsSeries C$136.8M$3.3B ($306.5M–$8.7B)60
Miragen Therapeutics, Inc. · BoulderBiotechnologySeries C$197.8M$3.3B ($281.5M–$8.3B)90
Adicet Bio, Inc. · MENLO PARKBiotechnologySeries C$116.8M$3.3B ($247.5M–$8.6B)30
Larimar Therapeutics, Inc. · BALA CYNWYDBiotechnologySeries C$201.0M$3.3B ($247.5M–$8.6B)60
Naurex Inc. · EVANSTONBiotechnologySeries C$156.0M$3.3B ($247.5M–$8.6B)70
Synlogic, Inc. · CAMBRIDGEBiotechnologySeries C$186.5M$3.3B ($247.5M–$8.6B)60
Paratek Pharmaceuticals Inc · BOSTONPharmaceuticalsSeries C$93.0M$3.3B ($302.1M–$8.6B)10
Snapcash lending, INC · CITY OF PASIGFintechSeries C$100.0M$3.2B ($371.2M–$8.6B)10
Code 42 Software, Inc. · MINNEAPOLISComputersSeries C$138.1M$3.2B ($331.0M–$8.5B)20
Sirnaomics, Inc. · GAITHERSBURGBiotechnologySeries C$162.0M$3.2B ($275.3M–$8.1B)50
Infinity Pharmaceuticals, Inc. · CAMBRIDGEBiotechnologySeries C$78.5M$3.2B ($243.0M–$8.5B)10
Sentia Wellness, Inc. · PORTLANDPharmaceuticalsSeries C$91.6M$3.2B ($297.4M–$8.5B)10
PagerDuty, Inc.Summer 2010 · SAN FRANCISCO
Real-time visibility into critical apps and services all in one place.
SaaS / SoftwareSeries C · Public$144.5M$3.2B ($348.0M–$8.5B)30
Amplyx Pharmaceuticals, Inc. · SAN DIEGOPharmaceuticalsSeries C$116.6M$3.2B ($296.6M–$8.4B)30
Silverback Therapeutics, Inc. · SEATTLEBiotechnologySeries C$139.3M$3.2B ($262.9M–$8.2B)40
Personal Genome Diagnostics Inc. · BALTIMOREBiotechnologySeries C$198.1M$3.2B ($302.3M–$7.7B)80
Celularity Inc. · WARRENBiotechnologySeries C$117.7M$3.2B ($240.4M–$8.4B)20
Turing Pharmaceuticals AG · BaarPharmaceuticalsSeries C$153.0M$3.2B ($293.2M–$8.3B)20
Cedilla Therapeutics, Inc. · CAMBRIDGEBiotechnologySeries C$82.6M$3.1B ($255.5M–$8.1B)10
Fluidigm Corp · SOUTH SAN FRANCISCOBiotechnologySeries C$111.0M$3.1B ($237.6M–$8.3B)40
aidol, LLC · IRVINEOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Aldol · KATYOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Aoex, Llc · KATYOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Cfunworld Ltd · IRVINEOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Mark Miner,INC · IRVINEOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Mobilitie Investments III, LLC · NEWPORT BEACHOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Open Text Corp · ONTARIO CANADAOther TechnologySeries C$200.0M$3.1B ($378.9M–$8.3B)20
PhunCoin, Inc. · AUSTINOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Singapore Orta Foundation Ltd. · SINGAPOREOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Sinoc INC · STORRSOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
vtoken, llc · KATYOther TechnologySeries C$100.0M$3.1B ($378.9M–$8.3B)10
Cylance Inc. · IRVINEOther TechnologySeries C$120.0M$3.1B ($378.9M–$8.3B)20
Verve Therapeutics, Inc. · CAMBRIDGEBiotechnologySeries C$94.0M$3.1B ($290.8M–$7.7B)10
Codiak BioSciences, Inc. · CambridgeBiotechnologySeries C$107.5M$3.1B ($236.7M–$8.3B)20
Icosavax, Inc. · SeattleBiotechnologySeries C$129.7M$3.1B ($308.5M–$7.4B)20
Gct Semiconductor Inc · SAN JOSEOther TechnologySeries C$334.9M$3.1B ($374.9M–$8.2B)50
Netsuite Inc · SAN MATEOOther TechnologySeries C$100.4M$3.1B ($374.7M–$8.2B)20
Workday, Inc. · PLEASANTONOther TechnologySeries C$183.6M$3.1B ($373.6M–$8.2B)20
Xanodyne Pharmaceuticals Inc · NEWPORTPharmaceuticalsSeries C$131.6M$3.1B ($285.1M–$8.1B)30
Ultragenyx Pharmaceutical Inc. · NOVATOBiotechnologySeries C$108.8M$3.1B ($232.0M–$8.1B)30
Tmunity Therapeutics, Inc. · PHILADELPHIABiotechnologySeries C$175.0M$3.1B ($232.0M–$8.1B)50
Electronic Arts Inc. · REDWOOD CITYOther TechnologySeries C$97.3M$3.1B ($368.7M–$8.1B)10
AbCellera Biologics Inc. · VANCOUVERBiotechnologySeries C$83.0M$3.1B ($230.5M–$8.0B)30
Tengion Inc · WINSTON-SALEMBiotechnologySeries C$121.7M$3.0B ($229.8M–$8.0B)40
Xilio Therapeutics, Inc. · WALTHAMBiotechnologySeries C$145.2M$3.0B ($293.9M–$7.3B)20
Casa Systems Inc · AndoverOther TechnologySeries C$99.6M$3.0B ($365.5M–$8.0B)20
Acadia Pharmaceuticals Inc · SAN DIEGOPharmaceuticalsSeries C$107.5M$3.0B ($280.6M–$8.0B)20
Genocea Biosciences, Inc. · CAMBRIDGEBiotechnologySeries C$153.6M$3.0B ($233.6M–$7.9B)50
Smartrent.Com, Inc. · ScottsdaleOther TechnologySeries C$132.1M$3.0B ($364.0M–$8.0B)40
Ligand Pharmaceuticals Inc · LA JOLLAPharmaceuticalsSeries C$85.4M$3.0B ($277.5M–$7.9B)10
Monte Rosa Therapeutics, Inc. · BOSTONBiotechnologySeries C$143.0M$3.0B ($293.9M–$7.2B)20
Oyster Point Pharma, Inc. · PRINCETONPharmaceuticalsSeries C$113.6M$3.0B ($276.1M–$7.9B)20
Spark Therapeutics, Inc. · PHILADELPHIABiotechnologySeries C$72.8M$3.0B ($225.2M–$7.9B)10
Datadog, Inc. · NEW YORKOther TechnologySeries C$147.2M$3.0B ($358.1M–$7.8B)50
Align Technology Inc · SANTA CLARABiotechnologySeries C$72.3M$3.0B ($223.6M–$7.8B)10
Fractal Industries, Inc. · RestonComputersSeries C$96.6M$3.0B ($303.8M–$7.8B)50
Homology Medicines, Inc. · BEDFORDPharmaceuticalsSeries C$127.1M$2.9B ($271.2M–$7.7B)20
ACV Auctions Inc. · BUFFALOOther TechnologySeries C$123.5M$2.9B ($352.4M–$7.7B)40
Petuum Holdings, Ltd. · PITTSBURGHOther TechnologySeries C$93.0M$2.9B ($352.4M–$7.7B)10
X-Co Holdings, LP · WilmingtonBiotechnologySeries C$71.0M$2.9B ($219.8M–$7.7B)10
ForgeRock, Inc. · SAN FRANCISCOOther TechnologySeries C$202.8M$2.9B ($350.6M–$7.7B)40
Terns Pharmaceuticals, Inc. · FOSTER CITYPharmaceuticalsSeries C$97.7M$2.9B ($317.3M–$7.1B)10
REGENXBIO Inc. · WASHINGTONBiotechnologySeries C$105.9M$2.9B ($218.1M–$7.6B)30
Auction.com, LLC · IrvineOther TechnologySeries C$91.7M$2.9B ($347.5M–$7.6B)10
C4 Therapeutics, Inc. · CambridgeBiotechnologySeries C$70.3M$2.9B ($217.5M–$7.6B)10
Intra-Cellular Therapies, Inc. · NEW YORKBiotechnologySeries C$70.3M$2.9B ($217.5M–$7.6B)10
Intellia Therapeutics, Inc. · CAMBRIDGEBiotechnologySeries C$70.0M$2.9B ($216.6M–$7.6B)10
Lime Light Holding Company, LLC · SAN FRANCISCOOther TechnologySeries C$91.0M$2.9B ($344.7M–$7.5B)10
Chiasma Inc · NEWTON CENTREBiotechnologySeries C$150.5M$2.9B ($215.7M–$7.5B)100
Life Biosciences LLC · BOSTONBiotech / PharmaSeries C$123.4M$2.8B ($237.1M–$7.5B)20
BI Global Connect Ltd · BELIZE CITYOther TechnologySeries C$90.0M$2.8B ($341.0M–$7.5B)10